These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6306393)

  • 41. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
    Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
    An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
    Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
    Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of bacterial antigens with the aid of sephadex gels.
    Söderholm J; Lundbeck H; Salenstedt CR; Billaudelle H; Tirunarayanan MO
    Prog Immunobiol Stand; 1967; 3():239-43. PubMed ID: 5379941
    [No Abstract]   [Full Text] [Related]  

  • 45. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
    Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
    J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.
    Ryan EJ; Nilsson L; Kjellman N; Gothefors L; Mills KH
    Clin Exp Immunol; 2000 Aug; 121(2):193-200. PubMed ID: 10931131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies.
    Presentini R; Perin F; Ancilli G; Rappuoli R; Bartoloni A; Lozzi L; Neri P; Antoni G
    Ann Sclavo Collana Monogr; 1986; 3(1-2):283-8. PubMed ID: 2892508
    [No Abstract]   [Full Text] [Related]  

  • 48. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
    Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
    Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [ATTEMPT AT DEMONSTRATION OF DISULFIDE BONDS IN TETANUS TOXIN AND DIPHTHERIA TOXIN].
    BIZZINI B; PRUDHOMME RO; TURPIN A; RAYNAUD M
    Bull Soc Chim Biol (Paris); 1963 Oct; 45():925-32. PubMed ID: 14095205
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. II. Effects of repeated pretreatments with crude toxin of Hemophilus pertussis and effects of anti-vaccine sera and the anti-crude sera on infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():301-8. PubMed ID: 13757277
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity.
    Redhead K; Sesardic D; Yost SE; Attwell AM; Watkins J; Hoy CS; Plumb JE; Corbel MJ
    Biologicals; 1994 Dec; 22(4):339-45. PubMed ID: 7779360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Animal venoms/toxins and the complement system.
    Tambourgi DV; van den Berg CW
    Mol Immunol; 2014 Oct; 61(2):153-62. PubMed ID: 24998802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Modified technic for electrosyneresis. Its application to the rapid identification of bacteria, toxins, antigens and antibodies].
    Dodin A; Brygoo ER
    C R Seances Soc Biol Fil; 1969 Feb; 162(7):1443-7. PubMed ID: 4181437
    [No Abstract]   [Full Text] [Related]  

  • 55. Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins.
    Pasechnik VA; Shone CC; Hambleton P
    Bioseparation; 1992-1993; 3(5):267-83. PubMed ID: 1369426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of Bordetella pertussis-specific immune memory by DTPa vaccines.
    Plotkin SA
    Vaccine; 2011 Dec; 29(52):9580; author reply 9581. PubMed ID: 21959329
    [No Abstract]   [Full Text] [Related]  

  • 57. Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines.
    Alsarraf H; Dedic E; Bjerrum MJ; Østergaard O; Kristensen MP; Petersen JW; Jørgensen R
    Virulence; 2017 Nov; 8(8):1880-1889. PubMed ID: 28430538
    [No Abstract]   [Full Text] [Related]  

  • 58. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins.
    Diethelm-Okita BM; Okita DK; Banaszak L; Conti-Fine BM
    J Infect Dis; 2000 Mar; 181(3):1001-9. PubMed ID: 10720523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.